Thursday, March 23, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Assessing Individual Protection Ensemble Performance

by Global Biodefense Staff
April 1, 2016
CBRN Individual Protection Ensemble Design Testing

Test and evaluation of CBRN Individual Protection Ensembles at Edgewood Chemical Biological Center.

CBRN Individual Protection Ensemble Design
ECBC’s Michael Kierzewski using software to evaluate an individual protection ensemble design.

The U.S. Army is conducting a market survey to identify potential qualified sources to support the development of the next version of the Individual Protection System Performance Model (IP SPM) for chemical and biological defense.

The IP SPM is a chemical and biological garment modeling suite of tools that can quantify overall protective and thermal performance of novel individual protection ensemble designs, as well as fielded IP systems, against identified threat agent scenarios.

The request for information seeks industry feedback on vendors that can provide specialized engineering services to continue developing the IP SPM at Edgewood Chemical and Biological Center. Vendors are required to demonstrate prior expertise in physics-based model development and algorithm development required to evaluate modern protective materials, protective garments and provide IP equipment developers with the information needed to evaluate garment performance under various threat conditions.

CBRN Individual Protection Ensemble Design Testing
Test and evaluation of CBRN Individual Protection Ensembles at ECBC.

Vendors must be familiar with current test equipment and methodology to conduct material swatch testing using chemical warfare agents, toxic industrial chemicals, toxic industrial materials and the design, fabrication & operation of the Chemical/Biological Agent Resistance Test (CBART) prototype cell in order to provide appropriate analysis and support.

Further details are available via Solicitation Number: W911SR16RIPSM. The response deadline is May 2, 2016.

Images courtesy of ECBC, adapted.

Tags: ECBCIndividual ProtectionRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC